| 4903 |
Centers for Disease Control and Prevention |
Html |
en |
Influenza Transmission Workshop, November 2010 |
null |
| Breakout Group Structure | 0.487873 |
| MS Word version | 0.698967 |
| Clifton Rd | 0.246066 |
| navigation Skip | 0.378621 |
| Content source | 0.200865 |
| Disease Control | 0.595897 |
| Influenza Transmission Workshop | 0.779305 |
| page options | 0.248525 |
| A-Z Index | 0.434079 |
| Dr. David Weissman | 0.42302 |
| Print page | 0.227609 |
| Workshop Definitions | 0.252275 |
| CDC Home CDC | 0.963493 |
| Workshop Agenda | 0.276607 |
|
| email updates | 0.220966 |
| Contact CDC | 0.428384 |
| list Skip | 0.381943 |
| CDC Scientific Agenda | 0.659646 |
| cdcinfo@cdc.gov | 0.217225 |
| different file formats | 0.37792 |
| Workshop Summary | 0.275479 |
| Breakout Group Summaries | 0.893516 |
| content Skip | 0.380508 |
| Clifton Road Atlanta | 0.378266 |
| Workshop Attendees | 0.280767 |
| CDC Flu | 0.460436 |
| Workshop Introduction | 0.430717 |
|
CLICK HERE |
| 6503 |
Centers for Disease Control and Prevention |
Html |
en |
Clinical and Laboratory Evaluation - Yellow Fever |
Information on Yellow Fever. Provided by the U.S. Centers for Disease Control and Prevention. |
| yellow fever | 0.976539 |
| viremic period | 0.568906 |
| renal insufficiency | 0.571142 |
| virus-specific immunoglobulin | 0.574843 |
| fever diagnostic testing | 0.703996 |
| symptom recrudescence | 0.56857 |
| local health department | 0.6119 |
| epigastric pain | 0.565608 |
| serum transaminase levels | 0.634216 |
| needle-puncture sites | 0.566752 |
| histopathologic specimens | 0.564732 |
| yellow fever virus | 0.867082 |
| acid amplification testing | 0.614386 |
| vaccination status | 0.573411 |
| yellow fever vaccine | 0.74543 |
| severe hepatorenal disease | 0.63073 |
| severe form | 0.576751 |
| severe headache | 0.587295 |
| time overt symptoms | 0.61404 |
| illness | 0.572961 |
| fever virus RNA | 0.726176 |
| cardiovascular instability | 0.569227 |
| mildest form | 0.58343 |
| sudden onset | 0.593725 |
|
| elevated prothrombin | 0.580091 |
| fever virus antigen | 0.731501 |
| testing serum | 0.585681 |
| bleeding diathesis | 0.571949 |
| RT-PCR results | 0.568428 |
| lumbosacral pain | 0.571263 |
| partial thromboplastin times | 0.61574 |
| transcription-polymerase chain reaction | 0.608511 |
| negative virus isolation | 0.635454 |
| self-limited infection | 0.572694 |
| platelet count | 0.565309 |
| Multiple laboratory abnormalities | 0.622642 |
| abrupt onset | 0.596845 |
| dermal icterus | 0.570666 |
| high fever | 0.679819 |
| plaque-reduction neutralization test | 0.614742 |
| hepatic enlargement | 0.569777 |
| epigastric tenderness | 0.570404 |
| uneventful recovery | 0.575021 |
| infected persons | 0.56839 |
| fibrin-split products | 0.564249 |
| yellow fever vaccination | 0.757447 |
| elevated body temperature | 0.649337 |
|
CLICK HERE |
| 7185 |
Centers for Disease Control and Prevention |
Html |
en |
CDC - Preventing Chronic Disease: Volume 9, 2012: 11_0305 |
We assessed the hypothesis that community affluence modifies the association between individual socioeconomic status (SES) and 6 cardiovascular disease (CVD) risk factors: diabetes, hypertension, physical inactivity, obesity, smoking, and poor nutrition. |
| cardiovascular disease | 0.308892 |
| individual ses | 0.440386 |
| Public Health | 0.361109 |
| modifiable risk factors | 0.291669 |
| median age | 0.277803 |
| health care services | 0.214133 |
| community affluence | 0.904446 |
| disease risk factors | 0.285407 |
| county median household | 0.396527 |
| Risk Factor Surveillance | 0.24041 |
|
| annual household income | 0.227659 |
| high-affluence communities | 0.336128 |
| Colorado Behavioral Risk | 0.254203 |
| modifiable CVD risk | 0.203156 |
| social determinants | 0.259639 |
| low SES | 0.339826 |
| median household income | 0.640164 |
| high SES | 0.237687 |
| Behavioral Risk Factor | 0.240651 |
| CVD risk factors | 0.797888 |
|
CLICK HERE |
| 7239 |
Centers for Disease Control and Prevention |
Html |
en |
Race/Ethnicity, Adults 18 to 49 Years at High-Risk - Estimates from the Behavioral Risk Factor Surveillance System (BRFSS), National Immunization Survey (NIS), and the National 2009 H1N1 Flu Survey (NHFS) |
Recent Influenza Vaccination Trends across Influenza Seasons, Race/Ethnicity, Adults 18 to 49 Years at High-Risk - CDC |
| Native Hawaiian | 0.46599 |
| Pacific Islander | 0.504656 |
| data | 0.403782 |
| report Final estimates | 0.516125 |
| season estimates | 0.297261 |
| United States | 0.295911 |
| influenza vaccination coverage | 0.636527 |
| methods | 0.294342 |
| U.S. civilian population | 0.44058 |
| Risk Factor Surveillance | 0.463888 |
| recent influenza seasons | 0.405687 |
| seasonal influenza vaccination | 0.947513 |
| Monovalent Vaccination Coverage | 0.505756 |
| vaccination coverage | 0.693373 |
| Alaska Native | 0.466462 |
| Excludes U.S. territories | 0.469512 |
| heart disease | 0.430709 |
| Additional estimates | 0.30212 |
| lung conditions | 0.291306 |
| estimates | 0.777445 |
|
| high risk conditions | 0.660825 |
| National Immunization Survey | 0.276118 |
| vaccination periods | 0.31568 |
| data sources | 0.219111 |
| influenza season | 0.471671 |
| high-risk conditions | 0.206199 |
| kidney conditions | 0.291521 |
| H1N1 Flu Survey | 0.445649 |
| Table 8-B | 0.205566 |
| Table 8-A | 0.205326 |
| confidence interval half-width | 0.464387 |
| BRFSS adult estimates | 0.387528 |
| Coverage estimates | 0.320127 |
| chronic illness | 0.466671 |
| Data Source | 0.385997 |
| vaccination recommendations | 0.320155 |
| vaccination data | 0.351434 |
| analytic methods | 0.207426 |
| national weighted estimates | 0.414587 |
| Behavioral Risk Factor | 0.464198 |
|
CLICK HERE |
| 8320 |
Centers for Disease Control and Prevention |
Html |
en |
The Social-Ecological Model: A Framework for Prevention |
null |
| close relationships | 0.213338 |
| housing opportunities | 0.215018 |
| closest social circle-peers | 0.418921 |
| single intervention | 0.236186 |
| potential prevention | 0.253465 |
| prevention efforts | 0.23473 |
| cultural norms | 0.227788 |
| level influence factors | 0.601862 |
| social isolation | 0.217 |
| healthy relationships | 0.207592 |
| acceptable way | 0.223993 |
| personal history factors | 0.575395 |
| physical environment | 0.215796 |
| workplace settings | 0.212436 |
| foster problem | 0.22186 |
| peer programs | 0.210071 |
|
| violence | 0.958229 |
| family-focused prevention programs | 0.413682 |
| four-level social-ecological model | 0.453201 |
| societal factors | 0.736743 |
| life skills | 0.221912 |
| large societal factors | 0.565098 |
| ultimate goal | 0.277265 |
| social relationships | 0.213727 |
| social policies | 0.213606 |
| factors | 0.882565 |
| family members-influences | 0.225092 |
| multiple levels | 0.241405 |
| social inequalities | 0.227721 |
| broad societal factors | 0.548079 |
| Prevention strategies | 0.506407 |
| Specific approaches | 0.224723 |
|
CLICK HERE |
| 10376 |
Centers for Disease Control and Prevention |
Html |
en |
Science Clips - Monday, March 10, 2014 |
CDC - Stephen B. Thacker Library - Science Clips |
| Haemophilus influenzae type | 0.560365 |
| Nichol ST | 0.596221 |
| Pediatr Infect Dis | 0.653535 |
| National Health Interview | 0.58535 |
| CDC Science Clips | 0.56922 |
| Emerg Infect Dis. | 0.911673 |
| colorectal cancer screening | 0.564339 |
| lymphocytic choriomeningitis virus | 0.612546 |
| Brief sexual histories | 0.56033 |
| parvum IId family | 0.560102 |
| Prenatal phthalate exposures | 0.556662 |
| risk factors | 0.561156 |
| body mass index | 0.569079 |
| Rollin PE | 0.590999 |
| Auditory risk estimates | 0.557812 |
| neurobehavioral development scores | 0.56034 |
| Int J Audiol. | 0.586651 |
| pulmonary tuberculosis patients | 0.560771 |
| Clin Infect Dis. | 0.614985 |
| high HIV-prevalence setting | 0.563583 |
| Adolesc Health. | 0.563198 |
| Environ Health Perspect. | 0.572092 |
| Dig Dis Sci. | 0.562056 |
| Croft JB | 0.572326 |
| Two-dose varicella vaccination | 0.559855 |
|
| AIDS Patient Care | 0.5672 |
| respiratory syncytial virus | 0.566806 |
| obstructive pulmonary disease | 0.580522 |
| multipremises feeder-rodent operation | 0.561859 |
| United States | 0.713455 |
| Borne Zoonotic Dis. | 0.577001 |
| public health community | 0.587568 |
| Afr Med J. | 0.565264 |
| Elevated transferrin saturation | 0.565846 |
| public health | 0.601963 |
| Feb | 0.752766 |
| public health literature | 0.56858 |
| Murphy WJ | 0.558603 |
| B. Thacker CDC | 0.562532 |
| Birth Defects Prevention | 0.561748 |
| Blaney DD | 0.566046 |
| Radiat Prot Dosimetry. | 0.557474 |
| Medical Care Survey | 0.577028 |
| acute febrile disease | 0.563677 |
| Infect Dis J. | 0.654234 |
| Subst Abuse Treat. | 0.556858 |
| routine HIV/STD testing | 0.562445 |
| public health research | 0.585922 |
| ensemble thermal characteristics | 0.560989 |
|
CLICK HERE |
| 10812 |
Centers for Disease Control and Prevention |
Html |
en |
Preventing Chronic Disease | Research to Reality: Moving Evidence Into Practice Through an Online Community of Practice - CDC |
How can a community of practice help further the practical application of cancer control research? In 2011, the National Cancer Institute (NCI) launched an online community of practice, Research to Reality (R2R). R2R aims to infuse evidence-based strategies into communities by engaging researchers and practitioners in a joint approach to research dissemination. To measure community growth and engagement, NCI measures data across 3 program domains: content, interaction, and activity. NCI uses Web analytics, usability testing, and content analyses to manage and evaluate R2R. As of December 2013, R2R had more than 1,700 registered members. More than 500 researchers and practitioners register for the monthly cyber-seminars, and 40% return each month. R2R hosts more than 15,500 page views and 5,000 site visits in an average month. This article describes the process of convening this online community and quantifies our experiences to date. |
| practical application | 0.347436 |
| R2R Mentorship Program | 0.352619 |
| community development | 0.330953 |
| planning evidence-based programs | 0.334375 |
| ongoing dialogue | 0.328955 |
| online community | 0.564073 |
| research dissemination activities | 0.330817 |
| evidence-based cancer control | 0.531822 |
| R2R Web platform | 0.343977 |
| Strong community partnerships | 0.345033 |
| R2R members | 0.365209 |
| evidence-based program planning | 0.329779 |
| Community Practice Measurements | 0.382578 |
| cancer control programs | 0.362162 |
| cancer control coalitions | 0.347979 |
| Cancer Control National | 0.35943 |
| clinical practice audience | 0.345256 |
| researchers | 0.39787 |
| community | 0.661783 |
| cancer control research | 0.533445 |
| community engagement | 0.410774 |
| federal government–sponsored community | 0.341424 |
| CIS Partnership Program | 0.616599 |
| R2R | 0.559961 |
| cancer control field | 0.354736 |
|
| NCI | 0.534462 |
| cancer control researchers | 0.384126 |
| cancer health disparities | 0.337124 |
| cancer control | 0.944846 |
| community practitioners | 0.342721 |
| Margaret M. Farrell | 0.375073 |
| Cancer Control P.L.A.N.E.T. | 0.482462 |
| R2R). | 0.33497 |
| Cancer Information Service | 0.333605 |
| everyday practice | 0.328285 |
| National Cancer Institute | 0.824196 |
| R2R cyber-seminar series | 0.330344 |
| public health | 0.333561 |
| cancer control science | 0.357034 |
| virtual community | 0.336711 |
| Madeline La Porta | 0.38091 |
| cancer control practice | 0.594269 |
| NCI’s program | 0.32919 |
| cancer control practitioners | 0.565179 |
| evidence-based programs | 0.361912 |
| community identity | 0.340432 |
| R2R community members | 0.448508 |
| evidence-based interventions | 0.410463 |
| monthly cyber-seminars | 0.395975 |
|
CLICK HERE |
| 11191 |
Centers for Disease Control and Prevention |
Html |
en |
Typhimurium Infections Linked to Microbiology Laboratories |June 2014 | Salmonella |
Human Salmonella Typhimurium Infections Linked to Exposure to Clinical and Teaching Microbiology Laboratories |
| college | 0.316886 |
| date | 0.315413 |
| teaching laboratories | 0.406041 |
| PulseNet | 0.332913 |
| human biology course | 0.452397 |
| CDC | 0.338546 |
| quality control purposes | 0.468124 |
| Indiana | 0.315131 |
| illnesses | 0.331717 |
| Salmonella Typhimurium | 0.815043 |
| microbiology course | 0.407121 |
| Public health investigators | 0.483897 |
| biosafety measures | 0.385143 |
| Salmonella infection | 0.452021 |
| commercially available strains | 0.520755 |
| ill persons | 0.969198 |
| deaths | 0.315396 |
| PFGE pattern | 0.388601 |
| diagnostic testing | 0.394544 |
| median age | 0.392496 |
| public health officials | 0.484184 |
| fingerprints | 0.319106 |
| different exposures | 0.387523 |
| Illinois | 0.315139 |
| Key Resources page | 0.451519 |
|
| pulsed-field gel electrophoresis | 0.475007 |
| national subtyping network | 0.480897 |
| Salmonella bacteria | 0.475459 |
| laboratory settings | 0.399912 |
| Salmonella Typhimurium strains | 0.601687 |
| regulatory agency laboratories | 0.483771 |
| writing utensils | 0.383379 |
| students | 0.328018 |
| percent | 0.334546 |
| states | 0.332489 |
| microbiology laboratory exposure | 0.53075 |
| total | 0.328925 |
| university teaching microbiology | 0.520237 |
| public health | 0.567727 |
| laboratory safety training | 0.455517 |
| cases | 0.316738 |
| specific guidance documents | 0.448602 |
| New Jersey | 0.389692 |
| food | 0.315738 |
| clinical microbiology laboratory | 0.485137 |
| lab coats | 0.382032 |
| Salmonella Typhimurium infections | 0.578815 |
| New Hampshire | 0.389759 |
| available information | 0.387629 |
|
CLICK HERE |
| 13776 |
Centers for Disease Control and Prevention |
Html |
en |
CDC and Food Safety | Food Safety | CDC |
Preventing foodborne illness and food safety depends on strong partnerships. CDC, the U.S. Food and Drug Administration (FDA), and the U.S. Department of Agriculture’s (USDA) Food Safety Inspection Service collaborate at the federal level to promote food safety. |
| CDC | 0.477675 |
| foodborne infections | 0.58948 |
| Antimicrobial Resistance Monitoring | 0.5407 |
| Modernization Act regulations | 0.529618 |
| U.S. Department | 0.440956 |
| state PulseNet laboratories | 0.538093 |
| food industries | 0.477817 |
| DNA fingerprinting | 0.547383 |
| foodborne illnesses | 0.82824 |
| U.S. Food | 0.477956 |
| multistate Listeria outbreak | 0.584203 |
| contaminated foods | 0.448747 |
| FDA Food Safety | 0.602666 |
| food safety action | 0.600581 |
| food animals | 0.456627 |
| monthly update | 0.438088 |
| rare Listeria strains | 0.564755 |
| international agencies | 0.431261 |
| traditional technique | 0.541402 |
| foodborne illness | 0.818133 |
| foodborne illness-causing bacteria | 0.752215 |
| foodborne outbreaks | 0.606461 |
| ill people | 0.506115 |
| costly—yet preventable—public health | 0.572066 |
|
| food safety challenge | 0.570877 |
| email address | 0.444158 |
| Drug Administration | 0.431253 |
| outbreak investigations | 0.462088 |
| Listeria contamination | 0.442979 |
| certain people | 0.431273 |
| recent work | 0.444353 |
| genome sequencing technology | 0.566532 |
| food safety goals | 0.601817 |
| public health burden | 0.538544 |
| antibiotic resistance | 0.69399 |
| specific foods | 0.431342 |
| Salmonella bacteria samples | 0.598183 |
| food producers | 0.476502 |
| DNA fingerprinting network | 0.533181 |
| local health departments | 0.751579 |
| food exposure | 0.455118 |
| CDC scientists | 0.465355 |
| food production | 0.459397 |
| food safety systems | 0.611496 |
| food safety | 0.994278 |
| infectious disease | 0.439206 |
| foodborne bacteria | 0.661756 |
| Campylobacter standards | 0.446973 |
|
CLICK HERE |
| 13921 |
Centers for Disease Control and Prevention |
Image |
null |
The Burning Truth: Controlled Tanning Is Not Safe Tanning |
null |
|
|
CLICK HERE |